Temporal changes in the gene signatures of BCG-vaccinated guinea pigs in response to different mycobacterial antigens

Vaccine

Volumn 28, Issue 50, 2010, Pages 7979-7986

  Tree, Julia A ^a   Patel, Jyoti ^a   Thom, Ruth E ^a   Elmore, Michael J ^a   Schäfer, Hubert ^b   Williams, Ann ^a   Marsh, Philip D ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Guinea pig; Microarray; Tuberculosis

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 8; MYCOBACTERIUM ANTIGEN; TUBERCULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; DNA MICROARRAY; GENE CONTROL; GENE EXPRESSION; GUINEA PIG; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFECTION PREVENTION; MYCOBACTERIUM BOVIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN CELL; TUBERCULOSIS;

ANIMALS; ANTIGENS, BACTERIAL; BCG VACCINE; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GUINEA PIGS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SPLEEN; TIME FACTORS; TUBERCULOSIS; UP-REGULATION;

EID: 78650248009     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.09.061     Document Type: Article

References (30)

1. Moreira A.L. Bacille Calmette-Gurein: efficiency and immunity. Tuberculosis 2005, 875-884. Lippincott Williams and Wilkins, Philadelphia, USA. 2nd ed. W.N. Rom, S.M. Garay, B.R. Bloom (Eds.).
2. Colditz G.A., Brewer T.F., Berkey C.S., Wilson M.E., Burdick E., Fineberg H.V., et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994, 271(Mar (9)):698-702.
3. Brewer T.F. Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature. Clin Infect Dis 2000, 31(Sep (Suppl. 3)):S64-S67.
4. Gupta U.D., Katoch V.M., McMurray D.N. Current status of TB vaccines. Vaccine 2007, 25(May (19)):3742-3751.
5. Williams A., Hatch G.J., Clark S.O., Gooch K.E., Hatch K.A., Hall G.A., et al. Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis. Tuberculosis (Edinburgh, Scotland) 2005, 85(Jan-Mar (1-2)):29-38.
6. Horwitz M.A., Harth G. A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis. Infect Immun 2003, 71(Apr (4)):1672-1679.
7. Horwitz M.A., Lee B.W., Dillon B.J., Harth G. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Nat Acad Sci USA 1995, 92(Feb (5)):1530-1534.
8. Flynn J.L., Cooper A.M., Bishai W. Animal models of tuberculosis. Tuberculosis and the tubercle bacillus 2005, 547-560. ASM Press, Washington, DC. S.T. Cole, K.D. Eisenach, D.N. McMurray, W.R. Jacobs (Eds.).
9. Williams A., Hall Y., Orme I.M. Evaluation of new vaccines for tuberculosis in the guinea pig model. Tuberculosis (Edinburgh, Scotland) 2009, 89(Nov (6)):389-397.
10. Tree J.A., Elmore M.J., Javed S., Williams A., Marsh P.D. Development of a guinea pig immune response-related microarray and its use to define the host response following Mycobacterium bovis BCG vaccination. Infect Immun 2006, 74(Feb (2)):1436-1441.
11. Braga-Neto U.M., Marques E.T. From functional genomics to functional immunomics: new challenges, old problems, big rewards. PLoS Comput Biol 2006, 2(Jul (7)):e81.
12. Parida S.K., Kaufmann S.H. Novel tuberculosis vaccines on the horizon. Curr Opin Immun 2010, 22(Jun (3)):374-384.
13. Tree J.A., Williams A., Clark S., Hall G., Marsh P.D., Ivanyi J. Intranasal bacille Calmette-Guerin (BCG) vaccine dosage needs balancing between protection and lung pathology. Clin Exp Immun 2004, 138(Dec (3)):405-409.
14. Jeevan A., Yoshimura T., Foster G., McMurray D.N. Effect of Mycobacterium bovis BCG vaccination on interleukin-1 beta and RANTES mRNA expression in guinea pig cells exposed to attenuated and virulent mycobacteria. Infect Immun 2002, 70(Mar (3)):1245-1253.
15. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5(10):R80.
16. Smyth G.K. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Gen Mol Biol 2004, 3:3-7.
17. Smyth GK, Thorne N, Wettenhall J. Limma: linear models for microarray data. Available from: ; 2005. http://bioinf.wehi.edu.au/limma/usersguide.pdf.
18. Benjamini Y., Hochbery Y. Controlling false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B 1995, 57:289-300.
19. Schafer H., Kliem G., Kropp B., Burger R. Monoclonal antibodies to guinea pig interferon-gamma: tools for cytokine detection and neutralization. J Immunol Meth 2007, 328(Dec (1-2)):106-117.
20. Raja A. Immunology of tuberculosis. Indian J Med Res 2004, 120(Oct (4)):213-232.
21. Basaraba R.J., Bielefeldt-Ohmann H., Eschelbach E.K., Reisenhauer C., Tolnay A.E., Taraba L.C., et al. Increased expression of host iron-binding proteins precedes iron accumulation and calcification of primary lung lesions in experimental tuberculosis in the guinea pig. Tuberculosis (Edinburgh, Scotland) 2008, 88(Jan (1)):69-79.
22. Pulendran B., Ahmed R. Translating innate immunity into immunological memory: implications for vaccine development. Cell 2006, 124(Feb (4)):849-863.
23. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007, 8(Sep (9)):950-957.
24. Wozniak T.M., Saunders B.M., Ryan A.A., Britton W.J. Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon. Infect Immun 2010, 78(October (10)):4187-4194.
25. Kamath A.T., Rochat A.F., Valenti M.P., Agger E.M., Lingnau K., Andersen P., et al. Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant. PloS One 2008, 3(11):e3683.
26. Forbes E.K., Sander C., Ronan E.O., McShane H., Hill A.V., Beverley P.C., et al. Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J Immunol 2008, 181(Oct (7)):4955-4964.
27. Lindenstrom T., Agger E.M., Korsholm K.S., Darrah P.A., Aagaard C., Seder R.A., et al. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J Immunol 2009, 182(Jun (12)):8047-8055.
28. Kamath A.T., Rochat A.F., Christensen D., Agger E.M., Andersen P., Lambert P.H., et al. A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells. PloS One 2009, 4(6):e5771.
29. Gonzalez-Juarrero M., Hattle J.M., Izzo A., Junqueira-Kipnis A.P., Shim T.S., Trapnell B.C., et al. Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection. J Leukoc Biol 2005, 77(Jun (6)):914-922.
30. Nambiar J.K., Ryan A.A., Kong C.U., Britton W.J., Triccas J.A. Modulation of pulmonary DC function by vaccine-encoded GM-CSF enhances protective immunity against Mycobacterium tuberculosis infection. Eur J Immunol 2010, 40(Jan (1)):153-161.